Cyclo Therapeutics, Inc.
CYTH · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,057 | -$15,451 | -$14,287 | -$8,942 |
| Dep. & Amort. | $19 | $19 | $17 | $13 |
| Deferred Tax | $0 | $0 | $0 | -$75 |
| Stock-Based Comp. | $737 | $514 | $471 | $271 |
| Change in WC | $3,063 | -$48 | -$1,228 | $117 |
| Other Non-Cash | $53 | -$148 | $22 | $75 |
| Operating Cash Flow | -$16,185 | -$15,114 | -$15,005 | -$8,540 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$15 | -$23 | -$53 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $53 | $37 | $39 |
| Investing Cash Flow | -$2 | $38 | $15 | -$14 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $7 | -$7 | $159 |
| Stock Issued | $9,739 | $160 | $18,764 | $18,458 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14,152 | $0 | $0 | $0 |
| Financing Cash Flow | $23,891 | $7 | $18,757 | $18,617 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $7,703 | -$15,069 | $3,767 | $10,062 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,543 | $16,613 | $12,846 | $2,784 |
| End Cash | $9,247 | $1,543 | $16,613 | $12,846 |
| Free Cash Flow | -$16,187 | -$15,129 | -$15,028 | -$8,593 |